FDA approves Investigational Device Exemption (IDE) for pivotal study and investment from St. Elizabeth Healthcare ...

AstraZeneca will acquire CinCor Pharma in a deal that aims to boost the British pharma giant’s cardiorenal pipeline, the company announced Monday. The $1.8 billion deal will give AstraZeneca CinCor’s ...

Although ultrafiltration (UF) in recent years has become increasingly popular as an alternative to intravenous diuretics for patients with acute decompensated heart failure with acute cardiorenal ...

Cardiorenal dysfunction encompasses a spectrum of conditions in which impairment of the heart and kidneys interact bidirectionally, amplifying organ injury and clinical risk. Central mechanisms ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted CardioRenal Systems breakthrough device designation for its RenalGuard Therapy, according to a ...

Jeffrey Turner, MD, discusses the discovery of cardiovascular and renal benefits in SGLT2 inhibitors, and Nihar R. Desai, MD, MPH, provides insight into the role of SGLT2 inhibitors in the four ...

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other ...

Jeffrey Turner, MD, and Nihar R. Desai, MD, MPH, provide insight into the identification of high-risk patients with cardiorenal metabolic syndrome and the impact of case-management resources on ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Erica, I can't ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Chiadi E. Ndumele, ...

Company to highlight therapy’s use at leading pediatric continuous renal replacement therapy educational conferenceMINNEAPOLIS, July 07, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a ...